Literature DB >> 23011715

Caring for the older person with chronic obstructive pulmonary disease.

Terri R Fried1, Carlos A Vaz Fragoso, Michael W Rabow.   

Abstract

Chronic obstructive pulmonary disease (COPD), a common disease in elderly patients, is characterized by high symptom burden, health care utilization, mortality, and unmet needs of patients and caregivers. Respiratory failure and dyspnea may be exacerbated by heart failure, pulmonary embolism, and anxiety; by medication effects; and by other conditions, including deconditioning and malnutrition. Randomized controlled trials, which provide the strongest evidence for guideline recommendations, may underestimate the risk of adverse effects of interventions for older patients with COPD. The focus of guidelines on disease-modifying therapies may not address the full spectrum of patient and caregiver needs, particularly the high rates of bothersome symptoms, risk of functional and cognitive decline, and need for end-of-life care planning. Meeting the many needs of older patients with COPD and their families requires that clinicians supplement guideline-recommended care with treatment decision making that takes into account older persons' comorbid conditions, recognizes the trade-offs engendered by the increased risk of adverse events, focuses on symptom relief and function, and prepares patients and their loved ones for further declines in the patient's health and their end-of-life care. A case of COPD in an 81-year-old man hospitalized with severe dyspnea and respiratory failure highlights both the challenges in managing COPD in the elderly and the limitations in applying guidelines to geriatric patients.

Entities:  

Mesh:

Year:  2012        PMID: 23011715      PMCID: PMC3815613          DOI: 10.1001/jama.2012.12422

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  101 in total

Review 1.  Clinical practice. Preventing falls in elderly persons.

Authors:  Mary E Tinetti
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

2.  What is the best evidence for determining harms of medical treatment?

Authors:  Jan P Vandenbroucke
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

3.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

4.  Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

Authors:  M T Claessens; J Lynn; Z Zhong; N A Desbiens; R S Phillips; A W Wu; F E Harrell; A F Connors
Journal:  J Am Geriatr Soc       Date:  2000-05       Impact factor: 5.562

Review 5.  Cognitive function in COPD.

Authors:  J W Dodd; S V Getov; P W Jones
Journal:  Eur Respir J       Date:  2010-04       Impact factor: 16.671

6.  Palliative care or end-of-life care in advanced chronic obstructive pulmonary disease: a prospective community survey.

Authors:  Patrick White; Suzanne White; Polly Edmonds; Marjolein Gysels; John Moxham; Paul Seed; Cathy Shipman
Journal:  Br J Gen Pract       Date:  2011-06       Impact factor: 5.386

7.  Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.

Authors:  David C Currow; Christine McDonald; Sheila Oaten; Bernadette Kenny; Peter Allcroft; Peter Frith; Michael Briffa; Miriam J Johnson; Amy P Abernethy
Journal:  J Pain Symptom Manage       Date:  2011-03-31       Impact factor: 3.612

8.  Perspectives on care at the close of life. Initiating end-of-life discussions with seriously ill patients: addressing the "elephant in the room".

Authors:  T E Quill
Journal:  JAMA       Date:  2000-11-15       Impact factor: 56.272

9.  Impairments in balance discriminate fallers from non-fallers in COPD.

Authors:  M K Beauchamp; K Hill; R S Goldstein; T Janaudis-Ferreira; D Brooks
Journal:  Respir Med       Date:  2009-07-09       Impact factor: 3.415

10.  Long-term effectiveness of an inpatient pulmonary rehabilitation program for elderly COPD patients: comparison between young-elderly and old-elderly groups.

Authors:  Hideki Katsura; Akiko Kanemaru; Kouichi Yamada; Takashi Motegi; Ritsuko Wakabayashi; Kozui Kida
Journal:  Respirology       Date:  2004-06       Impact factor: 6.424

View more
  27 in total

1.  Antihypertensive medications and physical function in older persons.

Authors:  Carlos A Vaz Fragoso; Gail J McAvay
Journal:  Exp Gerontol       Date:  2020-06-25       Impact factor: 4.032

2.  Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons.

Authors:  Brian S Marcus; Gail McAvay; Thomas M Gill; Carlos A Vaz Fragoso
Journal:  J Am Geriatr Soc       Date:  2015-01-30       Impact factor: 5.562

3.  An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.

Authors:  Gwen S Skloot; Paula J Busse; Sidney S Braman; Elizabeth J Kovacs; Anne E Dixon; Carlos A Vaz Fragoso; Nicola Scichilone; Y S Prakash; Christina M Pabelick; Sameer K Mathur; Nicola A Hanania; Wendy C Moore; Peter G Gibson; Susan Zieman; Betina B Ragless
Journal:  Ann Am Thorac Soc       Date:  2016-11

4.  Re-evaluation of the Uplift Clinical Trial Using Age-Appropriate Spirometric Criteria.

Authors:  Carlos A Vaz Fragoso; Linda S Leo-Summers; Thomas M Gill; Gail J McAvay
Journal:  Chest       Date:  2020-04-09       Impact factor: 9.410

5.  Re-evaluation of combination therapy in chronic obstructive pulmonary disease (COPD).

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Linda S Leo-Summers; Peter H Van Ness
Journal:  Respir Med       Date:  2019-03-29       Impact factor: 3.415

6.  Phenotype of normal spirometry in an aging population.

Authors:  Carlos A Vaz Fragoso; Gail McAvay; Peter H Van Ness; Richard Casaburi; Robert L Jensen; Neil MacIntyre; Thomas M Gill; H Klar Yaggi; John Concato
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

7.  Joint modeling of concurrent binary outcomes in a longitudinal observational study using inverse probability of treatment weighting for treatment effect estimation.

Authors:  George O Agogo; Terrence E Murphy; Gail J McAvay; Heather G Allore
Journal:  Ann Epidemiol       Date:  2019-05-02       Impact factor: 3.797

8.  Management dilemmas in pediatric nephrology: time-limited trials of dialysis therapy.

Authors:  Aaron Wightman
Journal:  Pediatr Nephrol       Date:  2016-12-09       Impact factor: 3.714

9.  Using time-limited trials to improve surgical care for frail older adults.

Authors:  Mark D Neuman; Steven Allen; Margaret L Schwarze; Joshua Uy
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

10.  Dyspnea in Community-Dwelling Older Persons: A Multifactorial Geriatric Health Condition.

Authors:  Brienne Miner; Mary E Tinetti; Peter H Van Ness; Ling Han; Linda Leo-Summers; Anne B Newman; Patty J Lee; Carlos A Vaz Fragoso
Journal:  J Am Geriatr Soc       Date:  2016-08-22       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.